Patients with both hepatocellular and chnlangiocarcinoma and their clinicopathological features
10.3760/cma.j.issn.1007-8118.2012.07.022
- VernacularTitle:肝细胞-胆管细胞混合型肝癌的诊治进展
- Author:
Kaijian CHU
;
Chongde LU
;
Xiaoping YAO
- Publication Type:Journal Article
- Keywords:
Combined hepatocellular and cholangiocarcinoma;
Pathological diagnosis and classification;
Clinical characteristics;
Prognoses
- From:
Chinese Journal of Hepatobiliary Surgery
2012;18(7):561-563
- CountryChina
- Language:Chinese
-
Abstract:
Combined hepatocellular and cholangiocarcinoma (HCC-CC) is a unique primary epithelial tumor of the liver classified by the WorldHealth Organization (WHO) as a tumor containing elements of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC).The clinical diagnosis is established by histopathology and a firm pathological diagnosis from definitive evidence of HCC and CC differentiation.HCC-CC's clinical features tend to resemble hepatocellular carcinoma in regards to venous infiltration and like cholangiocarcinoma with respect to lymph node metastasis.To date,the biological behavior of HCC-CC remains ill-defined; however its prognosis seems to be worse than just HCC.Conversely,it is unclear whether the prognosis of HCC-CC is better than that of only ICC.This paper reviews recent studies on the clinicopathological behavior of HCC-CC.